IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Author statistics

Author Identifier Number of Items Total Downloads
Al-Ejeh, F https://orcid.org/0000-0002-1553-0077 4 181

Items

Title Author(s) IrusType Repository Item URL Total Downloads
Breast cancer stem cells: Treatment resistance and therapeutic opportunities AL-Ejeh, Fares; Smart, Chanel E.; Morrison, Brian J.; Chenevix-Trench, Georgia; Lopez, J. Alejandro; Lakhani, Sunil R.; Brown, Michael P.; Khanna, Kum Kum Article University of Queensland [UQ eSpace] https://espace.library.uq.edu.au/view/UQ:242577 2
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia. Charmsaz, Sara; Beckett, Kirrilee; Smith, Fiona M.; Bruedigam, Claudia; Moore, Andrew S.; Al-Ejeh, Fares; Lane, Steven W.; Boyd, Andrew W. Article University of Queensland [UQ eSpace] https://espace.library.uq.edu.au/view/UQ:363748 36
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia Charmsaz, S.; Al-Ejeh, F.; Yeadon, T. M.; Miller, K. J.; Smith, F. M.; Stringer, B. W.; Moore, A. S.; Lee, F.-T.; Cooper, L. T.; Stylianou, C.; Yarranton, G. T.; Woronicz, J.; Scott, A. M.; Lackmann, M.; Boyd, A. W. Article University of Queensland [UQ eSpace] https://espace.library.uq.edu.au/view/UQ:457564 50
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib Bessette, Darrell C.; Tilch, Erik; Seidens, Tatjana; Quinn, Michael C. J.; Wiegmans, Adrian P.; Shi, Wei; Cocciardi, Sibylle; McCart-Reed, Amy; Saunus, Jodi M.; Simpson, Peter T.; Grimmond, Sean M.; Lakhani, Sunil R.; Khanna, Kum Kum; Waddell, Nic; Al-Eje Article University of Queensland [UQ eSpace] https://espace.library.uq.edu.au/view/UQ:360241 93
Jisc logo Cranfield logo CAVAL logo